A carregar...
Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events, specifically those related to heart failure in patients with type 2 diabetes. Reductions in major adverse cardiovascular event (MACE) outcomes are also observed, but confined largely to patients who have prior cardiovasc...
Na minha lista:
| Publicado no: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993195/ https://ncbi.nlm.nih.gov/pubmed/32003831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfz292 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|